OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending9/30/20189/30/20179/30/20169/30/2015
Net Income-13,236.9-23,810.996-25,766.198-15,197.865
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,124.5691,165.6891,189.2761,179.254
Adjustments To Net Income5,406.232,042.7555,143.8431,987.292
Changes In Accounts Receivables----
Changes In Liabilities-3,096.939654.2143,511.9841,331.12
Changes In Inventories----
Changes In Other Operating Activities310.617657.366-64.7947.214
Total Cash Flow From Operating Activities-9,492.423-19,290.972-15,985.889-10,692.985
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure--4.833-14.51-184.951
Investments----100
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities528.03888.452-14.51-284.951
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings-356.264-242.737-176.075-208.236
Other Cash Flows from Financing Activities----
Total Cash Flows From Financing Activities-86.26419,456.715-150.03426,454.765
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-9,050.649254.195-16,150.43315,476.829